CryoPort (NASDAQ:CYRX) issued its quarterly earnings data on Thursday. The consumer goods maker reported ($0.07) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.01, Briefing.com reports. CryoPort had a negative net margin of 62.80% and a negative return on equity of 45.60%. The company had revenue of $5.30 million for the quarter, compared to the consensus estimate of $5.06 million. During the same quarter in the prior year, the firm earned $0.08 earnings per share. The firm’s revenue for the quarter was up 76.7% compared to the same quarter last year.

CYRX stock traded down $0.19 during midday trading on Friday, reaching $11.37. 180,626 shares of the company’s stock traded hands, compared to its average volume of 217,421. CryoPort has a 52-week low of $6.02 and a 52-week high of $16.88. The stock has a market cap of $329.71 million, a P/E ratio of -33.44 and a beta of 1.42.

In other CryoPort news, CEO Richard J. Berman sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $12.81, for a total transaction of $256,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard J. Berman sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, September 6th. The shares were sold at an average price of $14.00, for a total transaction of $140,000.00. The disclosure for this sale can be found here. 9.60% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in CYRX. Strs Ohio purchased a new stake in shares of CryoPort in the second quarter worth $115,000. Metropolitan Life Insurance Co. NY purchased a new stake in shares of CryoPort in the second quarter worth $136,000. Greenwood Capital Associates LLC purchased a new stake in shares of CryoPort in the second quarter worth $163,000. FNY Investment Advisers LLC purchased a new stake in shares of CryoPort in the third quarter worth $147,000. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of CryoPort in the second quarter worth $192,000. 48.25% of the stock is owned by institutional investors and hedge funds.

A number of analysts have commented on CYRX shares. BidaskClub cut shares of CryoPort from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 25th. Cowen upped their target price on shares of CryoPort from $11.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 13th. Finally, B. Riley started coverage on shares of CryoPort in a report on Wednesday, October 10th. They set a “buy” rating and a $22.00 target price for the company. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. CryoPort has a consensus rating of “Buy” and an average target price of $19.75.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2018/11/10/cryoport-cyrx-issues-earnings-results-beats-estimates-by-0-01-eps.html.

About CryoPort

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Further Reading: Growth Stocks, What They Are, What They Are Not

Earnings History for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.